← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2003Last known activity
Jan 31, 2024
Timeline
1970s
- Jan 1, 1970
Universidade Estadual de Londrina— Founded
Drugs by trial phase (11 distinct, 17 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT06125002Overall official - principal investigatorPhase 1Jan 31, 2024
- NCT06125002Lead sponsorPhase 1Jan 31, 2024
- NCT06125002Sponsor investigatorPhase 1Jan 31, 2024
- NCT04213586CollaboratorN/ASep 1, 2019
- NCT04621383Reponsible party - principal investigatorN/AMay 27, 2019
- NCT04621383Study directorN/AMay 27, 2019
- NCT04621383Lead sponsorN/AMay 27, 2019
- NCT05541419Lead sponsorN/AAug 10, 2018
- NCT05541419Reponsible party - principal investigatorN/AAug 10, 2018
- NCT03556917CollaboratorPhase 2/Phase 3Jun 14, 2018
- NCT03621800CollaboratorN/AJun 7, 2018
- NCT03621800Study directorN/AJun 7, 2018
- NCT03236623CollaboratorN/AMay 10, 2017
- NCT03752359Lead sponsorN/AMar 13, 2017
- NCT03752359Study directorN/AMar 13, 2017
Details
- Founded
- Londrina, BR Jan 1, 1970
- Last known activity
- Jan 31, 2024